Reactions to clinical trial of Parkinson's drug to slow down ALS
A research team in Japan has published a small clinical trial in 20 people with amyotrophic lateral sclerosis (ALS) of a drug called ropinirole, which is commonly used in patients with Parkinson's disease. The authors, whose study is published in Cell Stem Cell, say the treatment is safe and slowed the progression of ALS - an incurable neurodegenerative disease - by an average of 27.9 weeks.
0